MedPath

A prospective, randomised study to compare the effectiveness of the 24 hour versus 12 hour double doses regimen of levonorgestrel for emergency post-coital contraceptio

Completed
Conditions
Contraception
Pregnancy and Childbirth
Registration Number
ISRCTN06428555
Lead Sponsor
World Health Organisation (WHO) (Switzerland)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
2071
Inclusion Criteria

1. Requesting emergency contraception within 120 hours of unprotected intercourse
2. Only one act of unprotected intercourse during current cycle
3. Willing to abstain from further acts during current cycle
4. Regular menstrual cycles (24 to 42 days)
5. Having at least one spontaneous cycle before current cycle
6. Available for follow-up in the next six weeks
7. Negative pregnancy test
8. Willing to participate
9. Not breastfeeding
10. No use of hormonal contraceptives or of rhythm or natural family planning method of contraception during current cycle
11. Not unsure about the date of last menstrual period

Exclusion Criteria

1. Post-abortion or post-partum patients whose period had not yet returned
2. Regular use of prescription drugs before admission to the study
3. Intercourse during the treatment cycle greater than 120 hours before admission into the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy rate
Secondary Outcome Measures
NameTimeMethod
1. Delay in onset of next menses<br>2. Incidence of side-effects
© Copyright 2025. All Rights Reserved by MedPath